Published in AIDS Weekly, November 23rd, 1998
The program has two parts - a clinical trial and a call for scientific projects. The trial provides free genotyping to individuals exposed to HIV; proposals from European virological and infectious diseases centers should plan to evaluate the clinical utility of HIV genotyping.
Charles A.B. Boucher, MD, PhD, University Hospital, Utrecht, The Netherlands, announced the program at a special symposium at the 4th International Congress on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.